Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocugen Inc
(NQ:
OCGN
)
1.420
-0.100 (-6.58%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ocugen Inc
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
21
22
Next >
Ocugen, Inc. (OCGN) Q3 2021 Earnings Call Transcript
November 09, 2021
OCGN earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
OCGN Stock Alert: The Earnings News That Has Ocugen Slipping Today
November 09, 2021
OCGN stock is pulling back after a muted earnings report this morning, as Ocugen makes a big bet on Covaxin for kids.
Via
InvestorPlace
7 Meme Stocks Ready to Regain Their Lost Momentum
November 09, 2021
Aggressive investors looking to profit off of the recent impressive volatility in certain companies may want to consider these meme stocks.
Via
InvestorPlace
2 Moonshots That Insiders Are Buying… and 3 They’re Not
November 09, 2021
The first several days of November saw insiders spend nearly $750 million buying up shares of their companies, which is worth your attention.
Via
InvestorPlace
Sell-the-News Moment Is Your Chance to Reload on Ocugen
November 09, 2021
Even as OCGN stock moves backward, Ocugen's moving forward with a crucial approval
Via
InvestorPlace
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
Where Will Ocugen Be in 3 Years?
November 08, 2021
Most likely in the doldrums, but it could be temporary.
Via
The Motley Fool
Exposures
COVID-19
Ocugen Stock Looks Poised to Take a Tumble Right Here
November 08, 2021
After WHO granted Covaxin a limited Emergency Use Listing, many institutions and hedge funds are likely to sell or short OCGN stock.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
Is Ocugen a Buy?
November 07, 2021
It'll take more than regulatory approvals of its vaccine for it to become a good investment.
Via
The Motley Fool
Exposures
COVID-19
Ocugen Seeks FDA Emergency Use Nod For Covaxin COVID-19 Vaccine In Kids
November 05, 2021
Ocugen Inc (NASDAQ: OCGN) said that it sent a request to the FDA for an emergency authorization for its COVID-19 vaccine candidate BBV152, known as Covaxin outside...
Via
Benzinga
Exposures
COVID-19
Product Safety
With Ocugen Stock: Follow The Lead of Traders and ‘Sell The News’
November 05, 2021
WHO approval for Covaxin doesn't change the game much for OCGN stock, steer clear as it slides back to lower prices.
Via
InvestorPlace
Exposures
COVID-19
Here's Why Shares of Moderna, Novavax, and Ocugen Have All Been Extremely Volatile This Week
November 05, 2021
Multiple earnings reports and regulatory updates shook up the coronavirus vaccine space this week.
Via
The Motley Fool
Exposures
COVID-19
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
November 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To...
Via
Benzinga
Exposures
COVID-19
Product Safety
This Surprising FDA Announcement Could Be Huge for Ocugen
November 05, 2021
The agency will allow vaccine boosters to be mixed and matched.
Via
The Motley Fool
Exposures
Product Safety
Is Ocugen's Surge Much Ado About Nothing?
November 05, 2021
The short answer: Yes.
Via
The Motley Fool
Exposures
COVID-19
81 Biggest Movers From Yesterday
November 05, 2021
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8...
Via
Benzinga
Avoid Ocugen — The Vaccine Is Too Little, Too Late
November 04, 2021
With high percentage of vaccination in U.S. and Canada, Ocugen has a limited addressable market. Limited cash flow visibility from vaccine. With the company still waiting for official FDA approval for...
Via
InvestorPlace
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Intraday Session
November 04, 2021
Gainers Evaxion Biotech (NASDAQ:EVAX) stock moved upwards by 157.5% to $16.74 during Thursday's regular session. Evaxion Biotech's stock is trading at a volume of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 04, 2021
Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million...
Via
Benzinga
4 Stocks Insiders Are Selling
November 04, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
55 Stocks Moving In Thursday's Mid-Day Session
November 04, 2021
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday. NerdWallet, Inc. (NASDAQ: NRDS) jumped 60% to $28.86 after the...
Via
Benzinga
24 Stocks Moving in Thursday's Pre-Market Session
November 04, 2021
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) rose 143.5% to $15.83 in pre-market trading after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) rose 72.6% to $4.09...
Via
Benzinga
86 Biggest Movers From Yesterday
November 04, 2021
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million....
Via
Benzinga
Ocugen Neared $16 Yesterday, But I’ll Eat 4 Hats If It Gets to $32
November 03, 2021
OCGN stock has moved higher despite little evidence anything’s changed regarding Ocugen’s revenue potential in the U.S.
Via
InvestorPlace
Exposures
COVID-19
Most Active Equity Options For Midday - Wednesday, Nov. 3
November 03, 2021
Top Tickers: TSLA, AMC, AMD, AAPL, F, BBBY, LCID, GME, BB, NVDA, Z, UBER, PLTR, HOOD, OCGN, AAL, ATVI, SOFI, PFE, FB.
Via
Talk Markets
Why Ocugen Stock Is Falling Today
November 03, 2021
The biotech received some good news for its most important product. So why is the stock down?
Via
The Motley Fool
Exposures
COVID-19
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 03, 2021
Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at...
Via
Benzinga
BZ Chart Of The Day: Will Ocugen Remember?
November 03, 2021
They say that markets have memories. It’s true, and holders and traders of Ocugen, Inc. (NASDAQ:
Via
Benzinga
Ocugen's India Partnered COVID-19 Vaccine Gets WHO Approval: Report
November 03, 2021
WHO's Technical Advisory Group has recommended the Emergency Use Listing status for Bharat Biotech's COVID-19, Covaxin. Read Next: Ocugen Reverses Course From Monday...
Via
Benzinga
Exposures
COVID-19
Here's Why Ocugen Stock Skyrocketed 64.9% in October
November 03, 2021
The biotech stock is now up a staggering 756% year to date.
Via
The Motley Fool
Exposures
COVID-19
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.